Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0001 USD | +9,900.00% |
|
0.00% | -50.00% |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
George Malesek
CEO | Chief Executive Officer | - | - |
James B. Smith
DFI | Director of Finance/CFO | - | 21-01-27 |
Charles Wagner
CHM | Chairman | - | 14-09-29 |
General Counsel | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Stefan Gruenwald
BRD | Director/Board Member | - | 19-10-07 |
Charles Wagner
CHM | Chairman | - | 14-09-29 |
Carlos Barnett
BRD | Director/Board Member | - | - |
Shawn Crouse
BRD | Director/Board Member | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 38,563,216 | 38,563,216 ( 100.00 %) | 0 | 100.00 % |
Company contact information
Oncology Pharma, Inc.
One Sansome Street Suite 3500
94104, San Francisco
+415-869-1036
![address Oncology Pharma Inc.(ONPH)](https://cdn.zonebourse.com/static/address/120787546.png)
Sector
1st Jan change | Capi. | |
---|---|---|
-50.00% | 38 | |
+59.97% | 827B | |
+38.38% | 634B | |
-6.18% | 350B | |
+15.61% | 319B | |
+8.44% | 294B | |
+12.68% | 240B | |
+14.40% | 221B | |
+0.04% | 219B | |
+9.68% | 167B |
- Stock Market
- Equities
- ONPH Stock
- Company Oncology Pharma Inc.